While overexpression of CD2 enhances the affinity between CAR-T cells and tumor cells, ensuring that this enhancement does not lead to excessive on-target, off-tumor toxicity, potentially harming healthy tissues expressing the target antigen, is vital. This evidence concerns the gene CD2 and neoplasm.